Device Week, Sept. 7, 2017 – The Impact Of 510(k) Exemptions
US FDA recently exempted hundreds of device types from 510(k) submissions under a 21st Century Cures Act mandate. On this week's podcast, we discuss Medtech Insight's exclusive analysis of the impact of the exemptions on companies and FDA.
You may also be interested in...
After an eleventh-hour win last year that saw Congress repeal the medical device excise tax, AdvaMed is going more global. CEO Scott Whitaker sat down with Medtech Insight for a lengthy chat about what the lobby group will focus on in 2020, including reimbursement challenges, the upcoming medical device user-fee negotiations, and negotiations with governments that are key to the industry ecosystem.
Following closely on the heels of a medical device tax repeal win, AdvaMed CEO Scott Whitaker sat down with Medtech Insight to discuss how the industry advocacy group ended the Obamacare excise tax and what it has in store for 2020.
US regulators and GE have notified health-care providers that the company’s nurse bay monitoring stations could be attacked by malicious hackers to turn off critical alarms that are intended to alert caregivers when a patient is in a critical state.